INTERFERÊNCIA DE MEDICAMENTOS UTILIZADOS NOS EXAMES LABORATORIAIS PARA MONITORAMENTO DE DISLIPIDEMIAS E DIABETES MELLITUS

Paulo Caleb Junior Lima Santos, Alexsandro Macedo Silva, Leiliane Rodrigues Marcatto, Vanessa Cristina Martins Silva, Ana Cristina Lo Prete, Bluette S. B. Pedrosa, Felipe Pomarole Santos, João Baptista J. Martins, Juliana Filassi Rosa, Luciana Aparecida da Silva, Luciane Maria Ribeiro Neto, Marion Coting Braga, Reiko Soraya Matsui, Sandro Jorge Januário, Valter Luiz da Costa Junior

Abstract


This is a literature review in order to warn about the interference of drugs on the results of laboratory tests, highlighting the main drugs that can alter the concentration of markers for diabetes mellitus and dyslipidemia. Parameters used to monitor these diseases were analyzed: frutosamine, glucose, glucagon, glycated hemoglobin, insulin, peptide C, TOTG, for diabetes mellitus; and total cholesterol, triglycerides, lipoprotein electrophoresis, HDL-cholesterol, LDL-cholesterol and VLDL-cholesterol, for dyslipidemia. For each marker, drug interference was systematized using tables. It is extremely important that the pharmacist works in clinical laboratories or pharmacies know how to recognize the possible interferences that the drugs can cause in laboratory tests.

 

Keywords: Dyslipidemia, Diabetes mellitus, Laboratory interference


Full Text: PDF

Refbacks

  • There are currently no refbacks.